Biomay Obtains FDA Approval for Manufacturing of Cas9 Nuclease at Headquarters Site
29.4.2025 14:00:00 CEST | news aktuell GmbH | Press release
The company announced its successful approval by the U.S. Food and Drug Administration (FDA) for the manufacturing, testing and release of recombinant Cas9 nuclease from its headquarters site. Cas9 is an essential component of CRISPR-based gene editing therapies, including CASGEVY® (exagamglogene autotemcel) developed and launched by Vertex Pharmaceuticals.
Biomay's recent achievement refers to an inspection by the FDA's Center for Biologics Evaluation and Research (CBER) at Biomay's headquarters manufacturing site in Vienna, Seestadt in December 2024. No observation was found, and no Form FDA 483 was issued by the authority, allowing Biomay's headquarters site to supply Cas9 for the United States.
Biomay operates two independent cGMP manufacturing sites, a headquarters facility in Vienna Seestadt, and a second site in Vienna downtown. The authority’s approval of Biomay's headquarters site represents the company's second successful FDA inspection following the 2023 approval of Biomay's downtown facility. Biomay's headquarters site is a recently constructed, state-of-the-art biomanufacturing facility.
Biomay AG is a privately owned and fully integrated Contract Development and Manufacturing Organization (CDMO) based in Vienna, Austria. Founded in 1984, the expression of recombinant proteins by utilizing E. coli has been Biomay's business focus from the very beginning. Today, Biomay offers cGMP services for manufacturing of therapeutic proteins, plasmid DNA (pDNA) and messenger RNA (mRNA). The company's scope of CDMO services comprises process and analytical development, cell banking, cGMP manufacturing of drug substance and aseptic filling of drug product.
Contact:
Dr. Angela Neubauer, SVP Client Business; E-Mail: request@biomay.com / Biomay AG, Ada Lovelace-Str. 2, A-1220 Vienna, Austria www.biomay.com
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist29.6.2026 12:28:23 CEST | Press release
The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year.
FRITZ: YouGov survey in 14 countries: Trust in router manufacturers from different regions European consumers mistrust Chinese routers29.6.2026 10:00:00 CEST | Press release
More than half of consumers in Norway mistrust routers from Chinese manufacturers (59%) Many mistrust devices made in the USA European routers enjoy a high level of trust across Europe (60%) For half of Europeans (55%), the ‘Made in Europe’ label important to when making a purchase
93% of Europe's Internet Traffic Flows Through Routers – Yet No One Is Paying Attention: Study Demands Action on Digital Sovereignty24.6.2026 10:00:00 CEST | Press release
Berlin, 24 June 2026 – The Sovereignty Alliance for European Network Technology (SAFENet), together with the Innovate Europe Foundation (IE.F) and Berlin-based consultancy iconomy, publishes a new foundational study revealing that 93% of European internet traffic flows through routers and yet the EU has no sovereignty framework for this key component of the digital ecosystem. Meanwhile, Chinese manufacturers already control 37% of the market.
Mein Schiff Flow officially named: three godmothers, one ship and a shared flow22.6.2026 13:33:00 CEST | Press release
Hamburg/Trieste, 21 Jun 2026. The big moment had arrived: to the applause of thousands of guests on board, the champagne bottle was smashed against the bow of Mein Schiff Flow. Accompanied by a spectacular show and an elaborately staged ceremony, the second ship in the InTUItion class was officially welcomed into the Mein Schiff fleet. The naming ceremony marked a first in several respects: for the first time in the history of TUI Cruises, three women – Julia, Annabelle and Karin – jointly acted as godmothers to the new ship. Together, they represent the diversity of the guests and the many personal stories that connect people with the Mein Schiff fleet. For their grand entrance, the three godmothers wore couture dresses selected by designer Guido Maria Kretschmer. A naming ceremony day to celebrate the motto “Go with the Flow” From the afternoon onwards, Mein Schiff Flow was entirely in keeping with the motto of its naming ceremony, “Go with the Flow”. The ship was transformed into an
A decade after the Brexit referendum: Time for European pragmatism22.6.2026 09:03:53 CEST | Press release
On June 23, 2016, British voters chose to leave the European Union, sending shockwaves across the continent. To mark the anniversary, the Bertelsmann Stiftung is publishing exclusive data tracking public opinion in the UK and the EU over the past ten years. The findings suggest that Brexit has neither triggered further EU fragmentation nor driven British and European public opinion permanently apart. Instead, they point to a shared preference for pragmatic cooperation.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom